A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SRSD107 in Healthy Chinese Subjects
Clinical trial NCT07655427 · COMPLETED
Trial details
- NCT number
- NCT07655427
- Sponsor
- Sirius Therapeutics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-29
- Primary completion
- 2025-03-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.